Q1 2025 vs Q1 2026 · 15 practices (12 full + 3 shallow) · Generated 2026-04-21
Portfolio production softened from $8,900,941 → $8,665,970 (-2.6% YoY) across the 12 covered practices. New patient volume moved from 1,632 → 1,634 (+2). The unscheduled active patient book holds $13,816,731 in reactivation opportunity across the portfolio — the single largest untapped dollar lever visible in this dataset. This rollup is for ROD / executive review; each practice has its own isolated report URL (noindex) for front-line team review.
To produce full reports for these practices, request Q1 2025 + Q1 2026 DI exports and re-run.
Cross-Portfolio Action Themes
Reactivation is the single biggest lever. $13,816,731 sits in unscheduled active patients across 12 practices. Pull the 6+ month overdue list from DI Analytics (not Engagement) and assign manual call queues per practice. Owner: Marketing + each Office Manager • Impact: 10% recovery = $1,381,673
PeerLogic coverage gap. 5 of 12 full practices (Benner, Moskowitz, Ressler, Riverside, Oakwood, Lakeshore, Smile Center) are not on PeerLogic — we cannot diagnose their call funnel. Onboard universally. Owner: ROD + IT • Impact: Unblocks call-conversion analysis portfolio-wide
Referral source attribution is inconsistent. Several practices have >20% missing referral source, blocking marketing ROI attribution. Mandate front-desk entry + daily audit. Owner: Each Office Manager • Impact: Enables future paid-media spend decisions
Appointment confirmation discipline varies widely. Leakage (cancel + no-show) ranges from low single digits to double-digits across the portfolio. Standardize 48-hour Engagement TouchPoint + manual phone backup + Park Column. Owner: Operations • Impact: Protects scheduled production
Spend recommendations should follow the funnel fix. Per priority-list framing, marketing spend is only justified after phone, conversion, and scheduling problems are addressed. Oakwood is the most likely candidate for spend increase; Pryor now has runway for both DTC implant and GP growth. Owner: Finance + Growth Lead • Impact: Sequenced investment
AI Analysis Disclaimer: This report was generated by an AI system combining Dental Intel Q1 2025 and Q1 2026 benchmark exports, PeerLogic Q1 2026 call data, and a priority-12 Google Business Profile scan. AI systems in dentistry are estimated at ~40% raw accuracy for clinical interpretation — every finding should be validated by the Market Manager, ROD, and Doctor before action is taken. Source CSVs are the ground truth; interpretations and recommended actions are directional.